-
Welcome to the WDWMAGIC.COM Forums!
Please take a look around, and feel free to sign up and join the community.
Coronavirus and Walt Disney World general discussion
- Thread starter Parker in NYC
- Start date
-
- Tags
- coronavirus covid covid-19
- Status
lazyboy97o
Well-Known Member
He could have died saving orphans from a fire and anti-vaxxers could find a way to twist it into a reason not to get vaccinated. They’re not arguing in good faith.
JoeCamel
Well-Known Member
Right, when there is no expectation of honesty from a person there is no reason to try to communicate with them.
Heppenheimer
Well-Known Member
Andrew C
You know what's funny?
Yowser.
www.foxnews.com
Sharks' Evander Kane suspended 21 games over fake COVID-19 vax card
San Jose Sharks star Evander Kane was suspended 21 games on Monday for submitting a fake COVID-19 vaccination card, the NHL announced.
www.foxnews.com
Disney Experience
Well-Known Member
For those interested in a light read concerning the exploration of the reason people who have had covid and then got vaccinated are better at dealing with covid variants compared to someone who only was vaccinated. Here is a non-technical nature article about the subject.
www.nature.com
Hopefully I have as good if not better advantage having been fully vaccinated 13 months ago and then getting moderate *Delta covid this last June. The best is to never get covid, but there are some silver linings.
Wife's one year visit for Phase 3 Moderna trial is this week.
COVID super-immunity: one of the pandemic’s great puzzles
People who have previously recovered from COVID-19 have a stronger immune response after being vaccinated than those who have never been infected. Scientists are trying to find out why.
www.nature.com
Hopefully I have as good if not better advantage having been fully vaccinated 13 months ago and then getting moderate *Delta covid this last June. The best is to never get covid, but there are some silver linings.
Wife's one year visit for Phase 3 Moderna trial is this week.
Tom P.
Well-Known Member
With that attitude, we might as well just throw in the towel now. With the exception of some young children, everyone who *wants* to be vaccinated has been at this point. If you want the vaccination rates higher, literally the only way to do it is to convince people who are hesitant for whatever reason. So either we keep trying to reach those people or we say that it's a lost cause and accept that today's vaccine level is where we're going to be permanently.
Andrew C
You know what's funny?
WSU coach Rolovich fired after refusing vaccine
Washington State fired football coach Nick Rolovich and four of his assistants on Monday after they refused to comply with a mandate that all state employees be vaccinated against COVID-19.
correcaminos
Well-Known Member
I am not told what tests or any results. I give 2-3 vials every visit. All results are theirs to look at. I am allowed to request the results of everything including covid tests after the trial is over. Though this trial I could get the covid test earlier if I wanted but nothing else.
GladToBeHear
Well-Known Member
Ain't freedom to make decisions about you and your family's own health a b*tch?
For the most part at this point it is going to be like seatbelts. Some people still do not wear their seatbelt and the only thing that MAY change them is (hopefully never) when their loved one dies from it.
"The Food and Drug Administration is planning to allow Americans to receive a different Covid-19 vaccine as a booster than the one they initially received, a move that could reduce the appeal of the Johnson & Johnson vaccine and provide flexibility to doctors and other vaccinators.
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, people familiar with the agency’s planning said. But vaccine providers could use their discretion to offer a different brand, a freedom that state health officials have been requesting for weeks.
The approach was foreshadowed on Friday, when researchers presented the findings of a federally funded “mix and match” study to an expert committee that advises the Food and Drug Administration. The study found that recipients of Johnson & Johnson’s single-dose shot who received a Moderna booster saw their antibody levels rise 76-fold in 15 days, compared with only a fourfold increase after an extra dose of Johnson & Johnson.
Federal regulators this week are aiming to greatly expand the number of Americans eligible for booster shots. The F.D.A. is expected to authorize boosters of the Moderna and Johnson & Johnson vaccines by Wednesday evening; it could allow the mix-and-match approach by then. The agency last month authorized booster shots of the Pfizer-BioNTech vaccine for at least six months after the second dose.
An advisory committee of the Centers for Disease Control and Prevention will take up the booster issue on Thursday; the agency will then issue its own recommendations. By the end of the week, tens of millions more Americans could be eligible for extra shots.
The study presented to the F.D.A.’s advisory panel last week, conducted by the National Institutes of Health, suggested that Johnson & Johnson recipients might benefit most from a booster shot of the Moderna vaccine. A shot of the Pfizer-BioNTech vaccine also raised the antibody levels of Johnson & Johnson recipients more than Johnson & Johnson did, the study found, although not as much as Moderna did. The N.I.H. researchers tested a full dose of Moderna’s vaccine for a booster shot, but regulators are also considering whether to authorize a half dose.
Experts emphasized last week that the new data was based on small groups of volunteers and short-term findings. Only antibody levels — one measure of the immune response — were calculated as part of the preliminary data, not the levels of immune cells primed to attack the coronavirus, which scientists say are also an important measure of a vaccine’s success.
The study’s researchers warned against using the findings to conclude that any one combination of vaccines was better. The study “was not powered or designed to compare between groups,” said Dr. Kirsten E. Lyke, a professor at the University of Maryland School of Medicine, who presented the data."
More at the link -
www.nytimes.com
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, people familiar with the agency’s planning said. But vaccine providers could use their discretion to offer a different brand, a freedom that state health officials have been requesting for weeks.
The approach was foreshadowed on Friday, when researchers presented the findings of a federally funded “mix and match” study to an expert committee that advises the Food and Drug Administration. The study found that recipients of Johnson & Johnson’s single-dose shot who received a Moderna booster saw their antibody levels rise 76-fold in 15 days, compared with only a fourfold increase after an extra dose of Johnson & Johnson.
Federal regulators this week are aiming to greatly expand the number of Americans eligible for booster shots. The F.D.A. is expected to authorize boosters of the Moderna and Johnson & Johnson vaccines by Wednesday evening; it could allow the mix-and-match approach by then. The agency last month authorized booster shots of the Pfizer-BioNTech vaccine for at least six months after the second dose.
An advisory committee of the Centers for Disease Control and Prevention will take up the booster issue on Thursday; the agency will then issue its own recommendations. By the end of the week, tens of millions more Americans could be eligible for extra shots.
The study presented to the F.D.A.’s advisory panel last week, conducted by the National Institutes of Health, suggested that Johnson & Johnson recipients might benefit most from a booster shot of the Moderna vaccine. A shot of the Pfizer-BioNTech vaccine also raised the antibody levels of Johnson & Johnson recipients more than Johnson & Johnson did, the study found, although not as much as Moderna did. The N.I.H. researchers tested a full dose of Moderna’s vaccine for a booster shot, but regulators are also considering whether to authorize a half dose.
Experts emphasized last week that the new data was based on small groups of volunteers and short-term findings. Only antibody levels — one measure of the immune response — were calculated as part of the preliminary data, not the levels of immune cells primed to attack the coronavirus, which scientists say are also an important measure of a vaccine’s success.
The study’s researchers warned against using the findings to conclude that any one combination of vaccines was better. The study “was not powered or designed to compare between groups,” said Dr. Kirsten E. Lyke, a professor at the University of Maryland School of Medicine, who presented the data."
More at the link -
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shots (Published 2021)
The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.
Andrew C
You know what's funny?
Poor J&J. I’ll take 3 of those if that will help them."The Food and Drug Administration is planning to allow Americans to receive a different Covid-19 vaccine as a booster than the one they initially received, a move that could reduce the appeal of the Johnson & Johnson vaccine and provide flexibility to doctors and other vaccinators.
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, people familiar with the agency’s planning said. But vaccine providers could use their discretion to offer a different brand, a freedom that state health officials have been requesting for weeks.
The approach was foreshadowed on Friday, when researchers presented the findings of a federally funded “mix and match” study to an expert committee that advises the Food and Drug Administration. The study found that recipients of Johnson & Johnson’s single-dose shot who received a Moderna booster saw their antibody levels rise 76-fold in 15 days, compared with only a fourfold increase after an extra dose of Johnson & Johnson.
Federal regulators this week are aiming to greatly expand the number of Americans eligible for booster shots. The F.D.A. is expected to authorize boosters of the Moderna and Johnson & Johnson vaccines by Wednesday evening; it could allow the mix-and-match approach by then. The agency last month authorized booster shots of the Pfizer-BioNTech vaccine for at least six months after the second dose.
An advisory committee of the Centers for Disease Control and Prevention will take up the booster issue on Thursday; the agency will then issue its own recommendations. By the end of the week, tens of millions more Americans could be eligible for extra shots.
The study presented to the F.D.A.’s advisory panel last week, conducted by the National Institutes of Health, suggested that Johnson & Johnson recipients might benefit most from a booster shot of the Moderna vaccine. A shot of the Pfizer-BioNTech vaccine also raised the antibody levels of Johnson & Johnson recipients more than Johnson & Johnson did, the study found, although not as much as Moderna did. The N.I.H. researchers tested a full dose of Moderna’s vaccine for a booster shot, but regulators are also considering whether to authorize a half dose.
Experts emphasized last week that the new data was based on small groups of volunteers and short-term findings. Only antibody levels — one measure of the immune response — were calculated as part of the preliminary data, not the levels of immune cells primed to attack the coronavirus, which scientists say are also an important measure of a vaccine’s success.
The study’s researchers warned against using the findings to conclude that any one combination of vaccines was better. The study “was not powered or designed to compare between groups,” said Dr. Kirsten E. Lyke, a professor at the University of Maryland School of Medicine, who presented the data."
More at the link -
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shots (Published 2021)
The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.
LittleBuford
Well-Known Member
Covid: Why are UK cases so high?
The UK has higher infections than most of its neighbours, as scientists fear a difficult winter.
www.bbc.com
ABQ
Well-Known Member
A spike protein test shows the presence of the proteins the vax instructs your body to produce, a stronger presence being better than weaker, these are the proteins that seemingly would wane and weaken over time and warrant the need for a booster, its what is boosted by that subsequent shot. The nucleic acid test would be a check for the actual virus being present and your body fighting it, meaning exposure and apparently contraction of the virus. Odds would be low that the second showed anything unless the one being tested was asymptomatic, but the spike protein test is certainly one that would be good to know. I know someone who was vaccinated back in Feb, 2nd dose of Pfizer and is still showing a strong presence of the protein. As that's now 8 months back and many people still are not eligible for a booster, it's comforting to know that the booster necessity may not be as imminent yet. My own second shot of Moderna was in the first week of March and there's been little movement on booster availability for myself yet. Not being in the population they are looking at right now.
DisneyCane
Well-Known Member
I wasn't discrediting anything. I was simply saying that the breakthrough data from the CDC is not complete. They tell you right on there that it isn't but don't disclose what is missing. Like all CDC death data, there is definitely a reporting lag as well.
DisneyCane
Well-Known Member
So Broward is that much less dense than Miami-Dade where it leads to lower spread with a lower vaccination rate?
DisneyCane
Well-Known Member
When people with AIDS die (which thankfully doesn't happen with the frequency now as it did in the 80s and 90s) don't they report that they died from AIDS complications not the specific infection which actually caused the death?
In the case of Secretary Powell, I'd say it's similar. Even though the SARS-CoV-2 infection is what ultimately killed him, it was the underlying cancer that was the reason it killed him.
Let's just say that I wouldn't use his case as an example to say the vaccines don't work.
DisneyFan32
Well-Known Member
- In the Parks
- Yes
It's just like end of the world but COVID-19 pandemic doomsday style. Get it?
I just want the pandemic will be over soon by next year.
Heppenheimer
Well-Known Member
This might be the difference between public perceptions and what actually goes on the death certificate. For AIDS, they usually reported the specific infection that killed them, if it was known (past tense used because fortunately, deaths from the consequences of HIV infection have become very rare in the developed world). For instance, cause of death was usually something like "Pneumocystis pneumonia", or just "pneumonia" if they didn't know exactly what organism caused it (this isn't always possible to know). "AIDS" would have been listed as the most significant underlying contributor, but the infection made possible by AIDS was ultimately the proximal cause of death, and this is what goes on the top of the death certificate.
Last edited:
- Status